• Medable: Real-World Evidence Needed To Address Health Disparities

    Clinical Research News | The pandemic has served to highlight the value of real-world evidence (RWE) in personalizing the delivery of care and potentially reducing disparities in access to treatment options, including clinical studies. To explore this “new frontier,” Medable has contracted with Kaiser Permanente to develop mobile apps designed to capture insights from informal caregivers, and digital biomarkers from wearable devices with patients, in fully decentralized trials.

    Apr 26, 2021
  • Biomarker Discovery Reveals Role of Lipids in Age-Related Pathologies

    Clinical Research News | Senescent cells can be good or bad actors when it comes to human health, but their steady accumulation with aging has adverse consequences that pharmaceutical companies are keen on reversing. Determining if a senolytic drug is working in the human body is a tough proposition, however, since the testing process often involves a biopsy and waiting long periods of time to determine whether a pathology has been ameliorated.

    Apr 21, 2021
  • How to Make Translations Work for Everyone

    Clinical Research News | When conducting a clinical trial on a global scale, sponsors assume a certain amount of risk in addition to significant management challenges, many of which can be attributed to communication. For this reason, comprehensive translation strategies are important to consider prior to moving forward with a clinical trial.

    Apr 19, 2021
  • Sanofi Reaping Rewards Of Site- And Patient-Centric Clinical Development

    Clinical Research News | Sanofi has succeeded in accelerating its clinical development timeline year over year, in large part by viewing patients as customers and key opinion leaders (KOLs), according to Victoria DiBiaso, vice president and regional head of the clinical studies unit in Asia Pacific, Eurasia, Middle East, and Africa. “What that means for patients is that we are developing meaningful healthcare solutions that are addressing unmet needs and we are doing it faster.”

    Apr 14, 2021
  • Patient Driven-Data: The Key to Improving the Health Ecosystem

    Clinical Research News | What are the benefits of Personal Health Records (PHRs) are, not just to patients, but to the wider health system? The most straightforward answer is this: patients who are engaged in their healthcare and understand their condition have better health outcomes. PHRs have a vital role to play in patient empowerment, effective clinical trials, and preventative and precision medicine around the world.

    Apr 13, 2021
  • Addressing Social Determinants Of Health To Improve Clinical Trial Diversity

    Clinical Research News | Health equality does not assure health equity, where the focus is on fixing root problems so access to tools and resources is possible across populations, according to Laurie Myers, global health literacy director at Merck.

    Apr 9, 2021
  • Pharma Needs To Better Understand Patients In Their Lived Environments

    Clinical Research News | Social and behavioral science is critical to the generation of real-world evidence (RWE) that reflects the patient perspective, according to Emily Freeman, Ph.D., senior director of patient insights in global R&D at Lundbeck Pharmaceuticals, and generating that evidence requires more multi-disciplinary expertise than is currently being brought to the table.

    Apr 8, 2021
  • At Janssen, Data Analytics Is Pivotal To Trial Success

    Clinical Research News | Janssen is using two homegrown data analytics solutions at scale to optimize clinical trials, enabling internal teams to solve real use cases embedded in the development process. The company is infusing real-world data (RWD) and data science into long-established processes to increase the operational success of trials and minimize patient burden.

    Apr 7, 2021
  • Leading After the Pandemic: Strategies to Guide the Future of Clinical Research

    Clinical Research News | A COVID-19 vaccine in one year is no small feat! What made it possible was the industry coming together in unprecedented ways and operating with a sense of urgency, spurring global cooperation for vaccine research, innovation, and distribution. We need to maintain this momentum at this critical junction, strengthen partnerships, and apply our learnings and knowledge to optimize clinical trials and accelerate the drug development process.

    Apr 6, 2021